Alkermes · 2 months ago
Director, Health Eco and Outcomes Research
Alkermes is a fully-integrated, global biopharmaceutical company committed to developing medicines for complex psychiatric and neurological disorders. The Director of Health Economics and Outcomes Research will play a pivotal role in executing evidence generation plans for sleep-wake disorders, focusing on high-impact research and material development to support stakeholder engagement.
BiotechnologyHealth CarePharmaceutical
Responsibilities
Executing on the HEOR plan for the alixorexton program, with patient populations including narcolepsy type 1 (NT1), narcolepsy type 2 (NT2), and idiopathic hypersomnia (IH)
Identifying and addressing evidence gaps and prioritizing real-world studies to inform treatment patterns, disease burden, patient-reported outcomes, and unmet needs
Developing and delivering high-quality HEOR evidence and value communication strategies to support optimal access and reimbursement aligned with the alixorexton program objectives
Gathering and synthesizing insights from payers, healthcare professional thought leaders, and HEOR experts
Collaborating with internal teams on publication strategies to ensure that dissemination of HEOR evidence is timely and has maximum impact across our key stakeholders with presentations at conferences and peer-reviewed manuscripts
Selecting and managing external research partners to ensure high-quality and timely study delivery
Qualification
Required
MA/MS degree in HEOR/related field and 8+ years of pharmaceutical industry experience in a HEOR role with direct research experience preferred; OR
PhD/PharmD in HEOR/related field and 5+ years of similar experience noted above
Strong technical background in HEOR
Excellent data science and visualization skills
Great written and verbal communication skills
Proven ability to foster and manage internal and external relationships effectively
Experience developing budget impact models (BIMs) and cost-effectiveness analyses (CEAs)
Experience conducting indirect treatment comparisons (ITCs)
Experience developing Academy of Managed Care Pharmacy (AMCP) Dossiers and pre-approval information exchange (PIE) slide decks
Experience in real-world evidence (RWE) generation such as studies of natural history, burden of illness, treatment patterns, etc. using different data sources including claims data, electronic health records (EHR), registries, chart reviews, and qualitative research
Preferred
Strong record of high-impact publications in peer-reviewed journals
Excellent communication, presentation, and collaboration skills across both internal and external stakeholders
Prior experience supporting a competitive product launch
Prior experience in rare disease or neurological disorders, including sleep-wake disorders such as narcolepsy and idiopathic hypersomnia, is a plus but not required
Excellent project management skills
Benefits
Annual performance pay bonus
Competitive benefits package
Company
Alkermes
Alkermes is a biotechnology company that develops, manufactures and commercializes medicines for the treatment of chronic diseases.
Funding
Current Stage
Public CompanyTotal Funding
$250MKey Investors
Primecap Management
2017-11-20Post Ipo Equity
2014-01-13Post Ipo Equity· $250M
2011-09-16IPO
Recent News
Bizjournals.com Feed (2025-11-12 15:43:17)
2026-01-16
Company data provided by crunchbase